These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 26315045

  • 1. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK, Gangwani RA, McGhee SM, Lian J, Wong DS.
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [Abstract] [Full Text] [Related]

  • 2. The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea.
    Ra H, Song LD, Choi JA, Jee D.
    PLoS One; 2018 Nov; 13(10):e0206690. PubMed ID: 30379971
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB.
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [Abstract] [Full Text] [Related]

  • 9. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
    Brown MM, Brown GC, Brown HC, Peet J.
    Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
    Nguyen HV, Tan GS, Tapp RJ, Mital S, Ting DS, Wong HT, Tan CS, Laude A, Tai ES, Tan NC, Finkelstein EA, Wong TY, Lamoureux EL.
    Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.
    van Katwyk S, Jin YP, Trope GE, Buys Y, Masucci L, Wedge R, Flanagan J, Brent MH, El-Defrawy S, Tu HA, Thavorn K.
    Value Health; 2017 Sep; 20(8):1034-1040. PubMed ID: 28964434
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study.
    Tamura H, Goto R, Akune Y, Hiratsuka Y, Hiragi S, Yamada M.
    PLoS One; 2015 Sep; 10(7):e0133628. PubMed ID: 26214804
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
    Stein JD, Newman-Casey PA, Kim DD, Nwanyanwu KH, Johnson MW, Hutton DW.
    Ophthalmology; 2013 Sep; 120(9):1835-42. PubMed ID: 23642372
    [Abstract] [Full Text] [Related]

  • 20. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants.
    Hopley C, Salkeld G, Wang JJ, Mitchell P.
    Br J Ophthalmol; 2004 Apr; 88(4):450-4. PubMed ID: 15031152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.